An introduction to vaccines and immunotherapy Flashcards

1
Q

what are the principles of vaccination?

A
  • vaccination aims to protect the individual and the population from the disease
  • herd immunity
  • immune system develops memory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is vaccination effective?

A

yes, leads to a massive drop in cases

an example is polio cases, which has been eradicated in most places following the polio vaccine (but not all).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types of vaccines

A
  1. living ones - natural or attenuated
  2. intact but non-living
  3. sub cellular fragments
  4. toxin based
  5. recombinant (DNA based)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe living vaccines (natural)

A

Living vaccines can be natural or attenuated

Live vaccines aren’t popular, Vaccinia (for pox virus) is the only one that’s been in widespread use. Too risky, but now looking at knocking out genes to render live virus safe, eg new Rotavirus vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe living vaccines (attenuated)

A

attenuated = less damaging

Very successful - virus ones better than bacterial ones.

Example is BCG - cultured for 13 years then becomes safe attenuated version. Successful if maintained in non-human species culture. Doesn’t have to keep virulence genes needed to grow in human cell.

Problem: sometimes its virulence genes that make inflammatory response, and we need the immune response to kick off.

other examples: Hep A (also killed vaccine), yellow fever, tuberculosis, measles (80% effective)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe dead vaccines

A

Range of effectiveness - rabies and Salk Polio are still pretty good

Sometimes issue – may not be as dead as think they are/ may induce disease state in v immunocompromised individuals

Less side effects from dead virus than attenuated - but, now being replaced by attenuated and subunit vaccines.

NB Salk polio vaccine, less effective than attenuated but also less risky. Since the chance of contracting polio has reduced this is making a comeback.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe toxin-based vaccines

A

Toxoid: Usually bacterial exotoxin, which has been inactivated by heat or chemical action (eg by formalin). Active against toxin-induced illness.

Example: Clostridium tetani is a common soil bacterium that causes tetanus. Inactivate toxin with formalin and give patient 3 doses, and a boost every 10 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe sub unit vaccines

A

Instead of whole virus. Use bits of them, e.g. take antigens.

Conjugate vaccines: Polysaccharides are usually not very immunogenic so conjugate to protein to get a better response (protein from same organism if poss, or give with tetanoid toxoid or diptheria). Get better response (IgG as well as IgM).

Polysaccharides don’t really generate good immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are vaccines Prophylactic or Therapeutic?

A

mix of both
Therapeutic = given once you get disease.
Prophylactic = before

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

examples of prophylactic vaccines

A

Smallpox;
Polio;
Tetanus (but needs booster!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of therapeutic vaccines

A

Rabies: rare case

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

rabies vaccine

A

Louis Pasteur generated vaccine against rabies.
Took material from rabies infected tissue.

Rabies travels up nerves and sits in CNS tissue - develops very slowly and can generate an immune response whilst its travelling up.

Get a rabies shot very quickly after being bit (to be within window of opportunity)

Can be used prophylactically in high-risk groups.
But therapeutically in post-exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cancer immunotherapy - what is it?

A

a therapy used to treat cancer patients that involves or uses components of the immune system

some cancer immunotherapies consist of:

  • antibodies that bind to and inhibit proteins expressed by cancer cells.
  • vaccines and T cell infusions

Take WBC from patient and generate DC. Load with patient’s tumour lysate. And put back into patient.
Other types of immunotherapy for cancer: TILs and CARs.

TILs – tumour infiltrating lymphocytes cars = chimeric antibody receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are adjuvants?

A

Adjuvants boost the immunogenicity of poor antigens (eg. some purified or recombinant proteins) and they initiate an inflammatory response.

They are usually responsible for the side-effects of vaccination (pain and swelling)

Recruit a lot immune cells, and some adjuvants have depot effect – retain immune cells at site. Recognise antigen better.

Examples: inorganic salts, liposomes, ISCOMs, bordetella perusis, interleukins, inferferons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

vaccine administration - diff ways

A

By injection, intramuscular or cutaneous! Target Langerhan cells in the skin

Danger of needlestick: HIV
Needlephobia!

Jet injectors – compressed air. Like an air pistol, forces under air vaccine under skin (part has to be changed each time otherwise get cross contamination. (attempt to improve vaccine delivery) - now maybe disposable single –use cartridges

Microneedle arrays, polymer breaks down quickly. Can incorporate peptide / proteins in it. Put on arm. When dissolve, release peptide they are carrying, into the skin. Lots of little needles = inflammation (does job for you).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mucosal immunisation

A

Most vaccines aren’t delivered by injection. Mimics natural exposure route

Attenuated vaccines work well, killed vaccines don’t.

Vaccine needs to penetrate through gut wall, use adjuvant such as partially inactivated toxoids. Balance between ‘some’ and ‘too much’ inflammation. Needs to be able to get through gut wall, may need adjuvant to make site leaky through inflammation.

Need to overcome the tolerance which is usually associated with food antigens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

parenteral v mucosal

A

parenteral = systemic action, but delivered by routes other than the GI tract, intravenous (IV), intramuscular (IM), subcutaneous (SC) and intradermal (ID) administration

mucosal = nasal, oral, ocular, rectal and vaginal cover a large surface of the body

18
Q

mucosal immunisation: nasal - example

A

Fluenz. Trivalent ‘flu vaccine: 3 live attenuated ‘flu strains.

Safe and well tolerated, licenced since 2003 USA

Nasally delivered - route is good, but not safe.

Safe and well tolerated.

Inability of vaccine strain to replicate in any cell other than nasopharyngeal epithelium

Safety regulation giving bugs nasally – due to it being close to brain.

Generating inflammation might be bad.

Some Inactivated flu vaccine, withdrawn, neuroligcal effects – bells palsy.

19
Q

why are live vaccines good?

A

They induce an appropriate immune response, and have many antigens to target

20
Q

why are killed vaccines good?

A

don’t produce a prolonged antigenic stimulus

21
Q

what might subunit vaccines need?

A

adjuvants, small antigens may have issues with MHC restriction.

22
Q

mild side effects of vaccination?

A

minor pain/swelling at injection site or fever

23
Q

1998?

A

paper associated MMR with autism and chronic bowel disease

-Andrew Wakefield associated MMR with autism

24
Q

safety problems of attenuated vaccines?

A
  • reversion to WT
  • persistent infection
  • hypersensitivity to viral antigens
    eg. VCZ, measles, mumps
25
Q

safety problems of killed vaccines?

A

vaccine not killed, yeast contaminant, contamination with animal viruses

26
Q

are vaccines restricted to certain groups? give examples

A

yes

  1. hep B (surface antigen) given to at risk ppl: medical staff, drug addicts
  2. tuberculosis (BCG) given as tropics at birth and 10-14 years old
  3. pneumococcal (polysaccharide) given to the elderly
  4. VCZ (attenuated) given to leukemic kids
27
Q

Future vaccines - costs?

A

Huge expense! Development costs in USA in 2013 was $200-400 million
Costs of $1 is prohibitively expensive in many of the world’s poorer countries
Even if cost of vaccine is low other costs, eg. cold-chain, transport, personnel etc. make it uneconomic

28
Q

Antivenin

A

antiserum containing antibodies against specific poisons in the venom of snakes, spiders, and scorpions.

Give antibodies.
Take venom in snake, put in another animal.
Drain blood from animal, should’ve generated response.
Collect it and purify.
Use this to protect against venom.

29
Q

Scary monsters and Super-beasts (Sic)

A

Australian paralysing tick has neuro toxin which injects (not just anticoagulant)
Box jellyfish. Stone fish. Puff adar.

30
Q

Coley’s toxins

A

mixture of killed bacteria - Streptococcus pyogenes and Serratia marcescens

31
Q

Cytokine therapy in cancer

A

Interleukin-2: T cell stimulus, NK, NKT
GM-CSF: APC maturation stimulus (differntiate)
Type 1 Interferon: activates a number of immune cells and upregulates MHC
Others: IL-1; IL-4; IL-7; IL-12; gIFN.

32
Q

HSP - role?

A

HSP 70/90 play a role in signalling protein function, trafficking and turnover.

HSP act as protection for the protein - proteins denature when they get hot and HSP forms scaffold around it.

Hsp derived from tumour lines is protective whereas hsp derived from normal tissue is not. Hsp70 and 90 taken out from tumour cells and used to vaccine against tumour. HSP from normal cells = no protection.

33
Q

examples of Therapeutic antibodies

A

Rituximab - anti CD20, used for CD20+ NH Lymphoma and CLL

Ipilimumab - anti CTLA4, used in metastatic melanoma

Bevacizumab (Avastin) - targets VEGF and blocks signalling, used against colon cancer, glioblastoma and kidney cancer.

34
Q

problems with non-specific actions of therapeutic antibodies?

A

Immune related adverse events! Mainly skin and GI and treated with corticosteroids.

35
Q

Cell-based immunotherapy for cancer

-innate immunity

A

LAK cells: Lymphokine activated killer cells. Mostly NK cells, crude prep
NK-T cells: Activated with a-galactosyl-ceramide
gd T cells: Use of Zoledronic acid
Dendritic cells: therapeutic vaccination.

Ways to target specific cells:
LAK cells – peripheral blood cells, taken out, add IL2 and put back in. activate a lot of cells - predominately NK cells.
DC loaded with antigen, to deliver antigen to immune system, and generate response.

36
Q

Cell-based immunotherapy for cancer

-adaptive immunity, TIL

A

Tumour Infiltrating Lymphocytes:

Smash tumour, get lymphocytes from tumour. They don’t work well against tumour. Take them out, expand using IL2. Put back in and better able to kill tumour.
Presence of lymphocytes has prognostic significance

Large numbers of TILs in many tumours
High numbers of CD8+ cells also has prognostic significance
High CD8+/Treg ratio.

Pre-existing antigen specificity of TILs has been correlated with outcome in immunotherapy of melanoma.

37
Q

Cell-based immunotherapy for cancer

-adaptive immunity, chimeric antibodies

A

CAR: high affinity Ab, tag intracellular bit of TCR. Ab outside, TCR on inside. So antibody directed to T cell tumour target.

Composed of Antibody recognition domain with cytoplasmic tail with multiple signalling domains that activate T cells.

Advantages of specificity and high affinity.

Not yet extensively studied
Disastrous case study: Patient with colon carcinoma, CAR against Erb-B2. Patient developed acute autoimmune response possibly due to low levels of antigen on Lung epithelium

Prob : immune system has evolved away from not targeting high affinity.
So sticking something with really high affinity on T cells, which has caused problems.

38
Q

Autoimmunity

A

Immunosuppressive therapy:
NSAIDs,
Steroids
Anti-inflammatory antibodies, eg anti-TNFa
Anti-inflammatory antibodies, works for a while until start mounting response against anitbodies.

Targeting autoreactive cells:
Rituximab and RA, anti CD20 targets B cells
Campath and RA, anti CD52/antiCD4 and lymphodepletion
Anti-idiotype
Target autoreactive cells. E.g. B cells in rheumatoid associated antibodies against IgG.

Tolerance therapy:
Re-training effector T cells to avoid recognizing auto-Ag. Ag-desensitization trialled in SLE, MS, and Grave’s disease.
T cell mediated disease e.g. SLE, MS. Try desensitising T cells, retrain by giving low dose antigen and build it up.

39
Q

Allergy - treatments

A

Antihistamines and Corticostroids
Corticosteroids to dampen down inflammatory response

Mast-cell stabilizers:
Sodium Chromoglycate  (stops release of histamine) 

Allergen insensitivity:
Progressive increase in dose of allergen to desensitize response. Best if started early in life.
Allergen insensitivity. Gradually increase dose of peanuts in allergic child. Tends to desensitise immune system. Develops tolerance.

40
Q

Monoclonal antibody therapy for infectious disease

A

Also use immune system to target infectious disease.

Respiratory syncytial virus (RSV) is a common, and very contagious, virus that infects the respiratory tract of most children before their second birthday.

Antibody against fusion protein in RSV. Protects against virus getting into host cell.

Palivizumab: prophylaxis in RSV disease
Humanized antibody against RSV ‘F’ protein
Blocks fusion of virus and host cell

Effective in protecting high-risk individuals and premature infants

41
Q

Idiotype

A

– area of antibody, which is specific for that antibody. Site that binds to antigen has specific confirmation. That is the idiotype. Can generate immune response against idiotype.

If have B cell tumour, cells have BCR on surface, that’s idiotype. Can generate immune response against it.